Clinical Trials Directory

Trials / Conditions / Cetuximab

Cetuximab

9 registered clinical trials studyying Cetuximab — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsa
NCT07506109
Tianjin Medical University Cancer Institute and HospitalPhase 2
RecruitingThe Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in F
NCT07257653
Zhejiang UniversityPhase 2
Not Yet RecruitingFirst-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable
NCT06616259
Meng QiuPhase 3
UnknownDevelopment of a Fluorescent Visualization System for Non-visible Lung Cancer Nodules
NCT06101394
University of Turin, ItalyPhase 2
UnknownCrisaborole Ointment for Skin Toxicity Induced by Cetuximab
NCT06118047
Sun Yat-sen UniversityPhase 2
UnknownNeoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy
NCT04923620
Shanghai Minimally Invasive Surgery Center—
RecruitingFirst-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes
NCT05022030
West China HospitalPhase 2
UnknownCetuximab Re-challenge for Colorectal Cancer Liver Metastasis
NCT04509635
Fudan UniversityPhase 3
UnknownEGFR Monoclonal Antibody for Advanced Gastric Cancer
NCT04136600
Shanghai Changzheng HospitalPhase 2